Terrie Curran, PRES., GLBL INFLAM. AND IMMUN. at Celgene, holds 10.14K shares in Arcutis Biotherapeutics (Ticker: ARQT), holds 381.57K shares in Phathom Pharmaceuticals (Ticker: PHAT), holds 0.00 shares in Myovant Sciences (Ticker: MYOV). Most recently, Terrie Curran Sold ― shares of Arcutis Biotherapeutics on Nov 13, 2024 for an estimated value of 94.17K.
Terrie Curran latest transaction was an Informative Sell of $94.17K.
What was Terrie Curran's most profitable transaction?
Terrie Curran’s most profitable transaction was an Informative Sell of PHAT stock on March 23, 2021. The return on the trade was 66.80%.
What is Terrie Curran's role in Celgene?
Terrie Curran's role in Celgene is PRES., GLBL INFLAM. AND IMMUN..
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.